APO Research
Talk to an analyst

APO RESEARCH · REPORT

Respiratory Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Respiratory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025188 pages

Choose your research edition.

Industry ResearchRespiratory Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Respiratory Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Respiratory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Respiratory Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Respiratory Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Respiratory Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Respiratory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Respiratory Drugs include Abbott, Pfizer, Amgen, Amgen, Horizon Pharma, FibroGen, Dr. Reddy's Laboratories, Dainippon Sumitomo and Afferent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Respiratory Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Respiratory Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Respiratory Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Respiratory Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Respiratory Drugs Segment by Company

Abbott

Pfizer

Amgen

Amgen

Horizon Pharma

FibroGen

Dr. Reddy's Laboratories

Dainippon Sumitomo

Afferent Pharmaceuticals

Respiratory Drugs Segment by Type

Asthma

Idiopathic Pulmonary Fibrosis

Cystic Fibrosis

Chronic Obstructive Pulmonary Disease

Respiratory Drugs Segment by Application

Ambulatory Care

Hospitals

Others

Respiratory Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Respiratory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Respiratory Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Respiratory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Respiratory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Respiratory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Respiratory Drugs Industry Trends Table 2. Respiratory Drugs Industry Drivers Table 3. Respiratory Drugs Industry Opportunities and Challenges Table 4. Respiratory Drugs Industry Restraints Table 5. Global Respiratory Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Respiratory Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Respiratory Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Respiratory Drugs Sales Market Share by Manufacturers Table 9. Global Respiratory Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Respiratory Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Respiratory Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Respiratory Drugs Manufacturers, Product Type & Application Table 13. Global Respiratory Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Respiratory Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Asthma Table 17. Major Manufacturers of Idiopathic Pulmonary Fibrosis Table 18. Major Manufacturers of Cystic Fibrosis Table 19. Major Manufacturers of Chronic Obstructive Pulmonary Disease Table 20. Global Respiratory Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Respiratory Drugs Sales by Type (2021-2026) & (k units) Table 22. Global Respiratory Drugs Sales by Type (2027-2032) & (k units) Table 23. Global Respiratory Drugs Sales Market Share by Type (2021-2026) Table 24. Global Respiratory Drugs Sales Market Share by Type (2027-2032) Table 25. Global Respiratory Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Respiratory Drugs Revenue by Type (2021-2026) & (k units) Table 27. Global Respiratory Drugs Revenue by Type (2027-2032) & (k units) Table 28. Global Respiratory Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Respiratory Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Ambulatory Care Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Others Table 33. Global Respiratory Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Respiratory Drugs Sales by Application (2021-2026) & (k units) Table 35. Global Respiratory Drugs Sales by Application (2027-2032) & (k units) Table 36. Global Respiratory Drugs Sales Market Share by Application (2021-2026) Table 37. Global Respiratory Drugs Sales Market Share by Application (2027-2032) Table 38. Global Respiratory Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Respiratory Drugs Revenue by Application (2021-2026) & (k units) Table 40. Global Respiratory Drugs Revenue by Application (2027-2032) & (k units) Table 41. Global Respiratory Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Respiratory Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Respiratory Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Respiratory Drugs Sales by Region (2021-2026) & (k units) Table 45. Global Respiratory Drugs Sales Market Share by Region (2021-2026) Table 46. Global Respiratory Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Respiratory Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Respiratory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 50. North America Respiratory Drugs Sales by Country (2027-2032) & (k units) Table 51. Europe Respiratory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 53. Europe Respiratory Drugs Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Respiratory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Respiratory Drugs Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Respiratory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Respiratory Drugs Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Respiratory Drugs Sales by Country (2027-2032) & (k units) Table 60. Global Respiratory Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Respiratory Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Respiratory Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Respiratory Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Respiratory Drugs Revenue Market Share by Region (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott Respiratory Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Abbott Respiratory Drugs Product Portfolio Table 69. Abbott Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Respiratory Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Pfizer Respiratory Drugs Product Portfolio Table 74. Pfizer Recent Development Table 75. Amgen Company Information Table 76. Amgen Business Overview Table 77. Amgen Respiratory Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Amgen Respiratory Drugs Product Portfolio Table 79. Amgen Recent Development Table 80. Amgen Company Information Table 81. Amgen Business Overview Table 82. Amgen Respiratory Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Amgen Respiratory Drugs Product Portfolio Table 84. Amgen Recent Development Table 85. Horizon Pharma Company Information Table 86. Horizon Pharma Business Overview Table 87. Horizon Pharma Respiratory Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Horizon Pharma Respiratory Drugs Product Portfolio Table 89. Horizon Pharma Recent Development Table 90. FibroGen Company Information Table 91. FibroGen Business Overview Table 92. FibroGen Respiratory Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. FibroGen Respiratory Drugs Product Portfolio Table 94. FibroGen Recent Development Table 95. Dr. Reddy's Laboratories Company Information Table 96. Dr. Reddy's Laboratories Business Overview Table 97. Dr. Reddy's Laboratories Respiratory Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Dr. Reddy's Laboratories Respiratory Drugs Product Portfolio Table 99. Dr. Reddy's Laboratories Recent Development Table 100. Dainippon Sumitomo Company Information Table 101. Dainippon Sumitomo Business Overview Table 102. Dainippon Sumitomo Respiratory Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Dainippon Sumitomo Respiratory Drugs Product Portfolio Table 104. Dainippon Sumitomo Recent Development Table 105. Afferent Pharmaceuticals Company Information Table 106. Afferent Pharmaceuticals Business Overview Table 107. Afferent Pharmaceuticals Respiratory Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Afferent Pharmaceuticals Respiratory Drugs Product Portfolio Table 109. Afferent Pharmaceuticals Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Respiratory Drugs Distributors List Table 113. Respiratory Drugs Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Respiratory Drugs Product Image Figure 2. Global Respiratory Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Respiratory Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Respiratory Drugs Sales (2021-2032) & (k units) Figure 5. Global Respiratory Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Respiratory Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Asthma Image Figure 9. Idiopathic Pulmonary Fibrosis Image Figure 10. Cystic Fibrosis Image Figure 11. Chronic Obstructive Pulmonary Disease Image Figure 12. Global Respiratory Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Respiratory Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Respiratory Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Respiratory Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Respiratory Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Respiratory Drugs Revenue Market Share by Type (2021-2032) Figure 18. Ambulatory Care Image Figure 19. Hospitals Image Figure 20. Others Image Figure 21. Global Respiratory Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Respiratory Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Respiratory Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Respiratory Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Respiratory Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Respiratory Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Respiratory Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Respiratory Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Respiratory Drugs Sales Market Share by Country (2021-2032) Figure 41. China Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Respiratory Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Respiratory Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Respiratory Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Respiratory Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Respiratory Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Respiratory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Respiratory Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Respiratory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Respiratory Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Respiratory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Respiratory Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Respiratory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Respiratory Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Respiratory Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Asthma
  • Idiopathic Pulmonary Fibrosis
  • Cystic Fibrosis
  • Chronic Obstructive Pulmonary Disease
Applications
  • Ambulatory Care
  • Hospitals
  • Others
Companies covered
  • Abbott
  • Pfizer
  • Amgen
  • Amgen
  • Horizon Pharma
  • FibroGen
  • Dr. Reddy's Laboratories
  • Dainippon Sumitomo
  • Afferent Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Respiratory Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Respiratory Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Respiratory Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Respiratory Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Respiratory Drugs Market Dynamics
  1. 2.1 Respiratory Drugs Industry Trends
  2. 2.2 Respiratory Drugs Industry Drivers
  3. 2.3 Respiratory Drugs Industry Opportunities and Challenges
  4. 2.4 Respiratory Drugs Industry Restraints
3 Respiratory Drugs Market by Manufacturers
  1. 3.1 Global Respiratory Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Respiratory Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Respiratory Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Respiratory Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Respiratory Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Respiratory Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Respiratory Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Respiratory Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Respiratory Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Respiratory Drugs Tier 1, Tier 2, and Tier 3
4 Respiratory Drugs Market by Type
  1. 4.1 Respiratory Drugs Type Introduction
  2. 4.1.1 Asthma
  3. 4.1.2 Idiopathic Pulmonary Fibrosis
  4. 4.1.3 Cystic Fibrosis
  5. 4.1.4 Chronic Obstructive Pulmonary Disease
  6. 4.2 Global Respiratory Drugs Sales by Type
  7. 4.2.1 Global Respiratory Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Respiratory Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Respiratory Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Respiratory Drugs Revenue by Type
  11. 4.3.1 Global Respiratory Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Respiratory Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Respiratory Drugs Revenue Market Share by Type (2021-2032)
5 Respiratory Drugs Market by Application
  1. 5.1 Respiratory Drugs Application Introduction
  2. 5.1.1 Ambulatory Care
  3. 5.1.2 Hospitals
  4. 5.1.3 Others
  5. 5.2 Global Respiratory Drugs Sales by Application
  6. 5.2.1 Global Respiratory Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Respiratory Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Respiratory Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Respiratory Drugs Revenue by Application
  10. 5.3.1 Global Respiratory Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Respiratory Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Respiratory Drugs Revenue Market Share by Application (2021-2032)
6 Global Respiratory Drugs Sales by Region
  1. 6.1 Global Respiratory Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Respiratory Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Respiratory Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Respiratory Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Respiratory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Respiratory Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Respiratory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Respiratory Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Respiratory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Respiratory Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Respiratory Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Respiratory Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Respiratory Drugs Revenue by Region
  1. 7.1 Global Respiratory Drugs Revenue by Region
  2. 7.1.1 Global Respiratory Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Respiratory Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Respiratory Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Respiratory Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Respiratory Drugs Revenue (2021-2032)
  8. 7.2.2 North America Respiratory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Respiratory Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Respiratory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Respiratory Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Respiratory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Respiratory Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Respiratory Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Respiratory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Respiratory Drugs Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Respiratory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Respiratory Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Amgen
  14. 8.3.1 Amgen Company Information
  15. 8.3.2 Amgen Business Overview
  16. 8.3.3 Amgen Respiratory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Respiratory Drugs Product Portfolio
  18. 8.3.5 Amgen Recent Developments
  19. 8.4 Amgen
  20. 8.4.1 Amgen Company Information
  21. 8.4.2 Amgen Business Overview
  22. 8.4.3 Amgen Respiratory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Respiratory Drugs Product Portfolio
  24. 8.4.5 Amgen Recent Developments
  25. 8.5 Horizon Pharma
  26. 8.5.1 Horizon Pharma Company Information
  27. 8.5.2 Horizon Pharma Business Overview
  28. 8.5.3 Horizon Pharma Respiratory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Horizon Pharma Respiratory Drugs Product Portfolio
  30. 8.5.5 Horizon Pharma Recent Developments
  31. 8.6 FibroGen
  32. 8.6.1 FibroGen Company Information
  33. 8.6.2 FibroGen Business Overview
  34. 8.6.3 FibroGen Respiratory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 FibroGen Respiratory Drugs Product Portfolio
  36. 8.6.5 FibroGen Recent Developments
  37. 8.7 Dr. Reddy's Laboratories
  38. 8.7.1 Dr. Reddy's Laboratories Company Information
  39. 8.7.2 Dr. Reddy's Laboratories Business Overview
  40. 8.7.3 Dr. Reddy's Laboratories Respiratory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dr. Reddy's Laboratories Respiratory Drugs Product Portfolio
  42. 8.7.5 Dr. Reddy's Laboratories Recent Developments
  43. 8.8 Dainippon Sumitomo
  44. 8.8.1 Dainippon Sumitomo Company Information
  45. 8.8.2 Dainippon Sumitomo Business Overview
  46. 8.8.3 Dainippon Sumitomo Respiratory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dainippon Sumitomo Respiratory Drugs Product Portfolio
  48. 8.8.5 Dainippon Sumitomo Recent Developments
  49. 8.9 Afferent Pharmaceuticals
  50. 8.9.1 Afferent Pharmaceuticals Company Information
  51. 8.9.2 Afferent Pharmaceuticals Business Overview
  52. 8.9.3 Afferent Pharmaceuticals Respiratory Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Afferent Pharmaceuticals Respiratory Drugs Product Portfolio
  54. 8.9.5 Afferent Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Respiratory Drugs Value Chain Analysis
  2. 9.1.1 Respiratory Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Respiratory Drugs Production Mode & Process
  6. 9.2 Respiratory Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Respiratory Drugs Distributors
  9. 9.2.3 Respiratory Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst